<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wohlschlegel J</submitter><funding>Foundation Fighting Blindness grant</funding><funding>Agence Nationale de la Recherche</funding><funding>IHU FOReSIGHT</funding><funding>Retina France</funding><funding>UNADEV</funding><funding>Fondation de France</funding><funding>LABEX LIFESENSES</funding><pagination>17210</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8390696</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>Integral Membrane Protein 2 B (ITM2B) is a type II ubiquitous transmembrane protein which role remains unclear. ITM2B mutations have been associated with different disorders: mutations leading to longer mutant proteins have been reported in two distinct Alzheimer-like autosomal dominant disorders with early-onset progressive dementia and cerebellar ataxia. Both disorders share neurological features including severe cerebral amyloid angiopathy, non-neuritic plaques, and fibrillary tangles as in Alzheimer disease. Our group reported a missense mutation in ITM2B, in an unusual retinal dystrophy with no dementia. This finding suggests a specific role of ITM2B in the retina. As the identification of retinal-specific ITM2B partners could bring new insights into the cellular functions of ITM2B, w</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>First identification of ITM2B interactome in the human retina.</pubmed_title><pmcid>PMC8390696</pmcid><funding_grant_id>ANR-10-LABX-65</funding_grant_id><funding_grant_id>ANR-11-IDEX-0004-0</funding_grant_id><funding_grant_id>[BR-GE-0619-0761-INSERM]</funding_grant_id><funding_grant_id>ANR-18-IAHU-0001</funding_grant_id><pubmed_authors>Thuret G</pubmed_authors><pubmed_authors>Leger T</pubmed_authors><pubmed_authors>Audo I</pubmed_authors><pubmed_authors>Argentini M</pubmed_authors><pubmed_authors>Forster V</pubmed_authors><pubmed_authors>Condroyer C</pubmed_authors><pubmed_authors>Michiels C</pubmed_authors><pubmed_authors>Letellier C</pubmed_authors><pubmed_authors>He Z</pubmed_authors><pubmed_authors>Wohlschlegel J</pubmed_authors><pubmed_authors>Zeitz C</pubmed_authors></additional><is_claimable>false</is_claimable><name>First identification of ITM2B interactome in the human retina.</name><description>Integral Membrane Protein 2 B (ITM2B) is a type II ubiquitous transmembrane protein which role remains unclear. ITM2B mutations have been associated with different disorders: mutations leading to longer mutant proteins have been reported in two distinct Alzheimer-like autosomal dominant disorders with early-onset progressive dementia and cerebellar ataxia. Both disorders share neurological features including severe cerebral amyloid angiopathy, non-neuritic plaques, and fibrillary tangles as in Alzheimer disease. Our group reported a missense mutation in ITM2B, in an unusual retinal dystrophy with no dementia. This finding suggests a specific role of ITM2B in the retina. As the identification of retinal-specific ITM2B partners could bring new insights into the cellular functions of ITM2B, w</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2026-05-08T00:39:53.376Z</modification><creation>2022-02-11T10:08:54.006Z</creation></dates><accession>S-EPMC8390696</accession><cross_references><pubmed>34446781</pubmed><doi>10.1038/s41598-021-96571-6</doi></cross_references></HashMap>